What is UnicCa®?

Triple roughness + free calcium ions

Blood clot forming on a BTI implant with the UnicCa® surface
A stable clot on the UnicCa® surface: calcium ions released on contact take part in the coagulation cascade and activate platelets.

The surface of BTI implants consists of a chemical modification with calcium ions over a triple roughness. Roughness is engineered by zone (neck, threads, valleys) and the chemistry is engineered for the first minutes after insertion.

Do not confuse

UnicCa® is not a calcium-titanate nor a calcium-phosphate / hydroxyapatite coating. The calcium ions sit on the titanium oxide and are released into the blood; nothing can delaminate.

Certified pureness

BTI UnicCa® is the first implant system on the market awarded the CleanImplant Foundation Trusted Quality Mark (2017 – 2026), a guarantee of the highest quality of its materials and surface, verified on production implants.

Triple roughness

Each zone of the implant meets a different tissue

The topography changes along the implant so each area suits the tissue and the biomechanical need it meets.

BTI implant showing neck, threads and valleys roughness zones
Neck · Sdr 40 – 60 %
Attenuated roughness

A BTI neck is neither machine-polished nor shot-blasted-and-acid-washed. Its reduced roughness enhances marginal tissue retention and resists bacterial adhesion, which protects the marginal bone and the gingiva.

Threads · Sdr > 200 %
High roughness

Allows bone anchorage outside the threads: more mechanical anchoring in the bone, better primary stability from the first day.

Valleys
Medium roughness

Guides bone growth between the threads while maintaining the implant's mechanical properties.

3D profilometry of the UnicCa® triple roughness
Three-dimensional profile of the UnicCa® roughness.
Electron-microscope view of calcium ions on the UnicCa® surface
Calcium ions (Ca²⁺) on the surface under the electron microscope.
Why free calcium ions?

Healing starts the moment the implant is fitted

01
Calcium is a co-factor of coagulation

Ionised calcium is a necessary co-factor in the coagulation cascade and helps platelet adhesion and activation on the titanium surface.

02
Released on contact

The release of calcium from the UnicCa® surface happens as soon as the implant is fitted. Fifteen minutes later a stable clot covers the implant.

03
Cells are stimulated from insertion

The surface is electropositive, clean and super-hydrophilic, so blood proteins and platelets bind immediately and the regenerative process begins without delay.

Blood clot retained on a UnicCa® component
The clot adheres to the calcium-modified surface instead of sliding off.
BTI implants immersed in Endoret® PRGF
UnicCa® implants in Endoret® (PRGF): the surface is designed to work with the patient's own plasma.
Bone formation

Ionised calcium accelerates osseointegration

Calcium is essential for bone regeneration: it drives organic-matrix mineralisation and signals bone cells through the calcium-sensing receptor. The animal studies below measured what that means at the implant.

Early bone formation

In dog-maxilla models, sequential-healing studies compared UnicCa® with a calcium-phosphate-modified surface and with a hydrophilic SLA-type surface and reported earlier bone-to-implant contact on UnicCa® (Favero 2015, two studies).

Gap model, rabbit femoral condyle

Bone-to-implant contact in the gap was significantly higher on UnicCa® than on the same surface without calcium, and higher still when UnicCa® was combined with PRGF-Endoret® at 8 weeks (Anitua 2015).

Delayed bone formation

The percentage of mineralised bone in contact with the surface stayed higher on UnicCa® in the later healing phases of the same dog models, i.e. the effect is not limited to the first weeks.

In a sheep-tibia model of poorly vascularised bone, bone-to-implant contact at 12 weeks was likewise significantly higher on UnicCa® than on the surface without calcium (CAT112, ref. 4). Animal and in-vitro findings are reported as such; statistically significant differences p < 0.05 per the source studies.
Peri-implant health

The neck that resists bacteria

Bacterial adhesion after 1 h and 24 h

Compared with a machined neck and with a shot-blasted + acid-washed neck, the BTI neck showed significantly lower adhesion of Aggregatibacter actinomycetemcomitans and Streptococcus sanguinis after one hour and after 24 hours (Anitua, Biomaterials 2016).

Biofilm under saliva flow

Under a flow of human saliva from healthy donors, biofilm of S. mutans and A. actinomycetemcomitans grew less over days on UnicCa® combined with Endoret® than on machined or sand-blasted + acid surfaces.

Four species tested

C. albicans, A. actinomycetemcomitans, S. sanguinis and S. mutans all adhered less to the BTI neck than to the rougher alternatives (Pachá 2016, statistically significant).

What it means at the chair

Marginal bone and gingival tissue are maintained around the reduced-roughness neck, which is how BTI states UnicCa® reduces the risk of peri-implantitis.

UnicCa® implant placed in a fresh socket
Purity certificate

The CleanImplant Foundation analyses production implants for particulate and organic contamination. BTI UnicCa® holds the Trusted Quality Mark for 2017 – 2026, renewed on each audit. Integra provides the certificate and the CE declarations for your practice records.

References

Sources

  1. Anitua E, Prado R, Orive G, Tejero R. Effects of calcium-modified titanium implant surfaces on platelet activation, clot formation, and osseointegration. J Biomed Mater Res A 2015;103:969-80.
  2. Anitua E, Tejero R, Pachá MA, Zalduendo MM, Troya M, González M. Balancing infection and tissue-integration on calcium-ion modified titanium implant surfaces. Biomaterials 2016.
  3. Pachá MA, Anitua E, Tejero R, et al. Implant surface balances in bacterial adhesion. J Biomed Mater Res A 2016.
  4. Anitua E, Tejero R, Pacha-Olivenza MA, et al. Balancing microbial and mammalian cell functions on calcium ion-modified implant surfaces. J Biomed Mater Res B 2017.
  5. Favero R, Botticelli D, et al. Sequential healing at calcium- versus calcium phosphate-modified titanium implant surfaces: an experimental study in dogs. Clin Implant Dent Relat Res 2015.
  6. Favero V, Lang NP, et al. Sequential healing events of osseointegration at UnicCa® and SLActive® implant surfaces: an experimental study in the dog. Clin Oral Implants Res 2015.
  7. Tejero R, et al. Time-of-flight secondary ion mass spectrometry with principal component analysis of titania–blood plasma interfaces. Langmuir 2013;29:902-912.
  8. Weisel JW. Fibrinogen and fibrin. Adv Protein Chem 1984;70:247-299. · Gorbet MB, Sefton MV. Biomaterial-associated thrombosis. Biomaterials 2004;25:5681-5703. · Park JY, et al. Platelet interactions with titanium. Biomaterials 2001;22:2671-2682.
  9. Habibovic P, Barralet JE. Bioinorganics and biomaterials: bone repair. Acta Biomater 2011;7:3013-3026. · Marie PJ. The calcium-sensing receptor in bone cells. Bone 2010;46:571-576.

Content adapted from BTI CAT112 UnicCa® Surface (12/2024) and BTI's UnicCa® scientific presentation. UnicCa®, Endoret® and BTI® are trademarks of BTI Biotechnology Institute S.L.